Group B Streptococcus Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age
Condition: Group B Streptococcal Infections Interventions: Biological: Multivalent group B streptococcus vaccine; Biological: Placebo Sponsor: Pfizer Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2017 Category: Research Source Type: clinical trials
A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age
Condition: Group B Streptococcal Infections Interventions: Biological: Multivalent group B streptococcus vaccine; Biological: Placebo Sponsor: Pfizer Not yet recruiting - verified May 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2017 Category: Research Source Type: clinical trials
Group B Streptococcus (GBS) Infection and in Preterm Labor Women Conceived Through IVF
Condition: Preterm Labor Intervention: Procedure: GBS screening Sponsor: Manh Tuong Ho Withdrawn - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2015 Category: Research Source Type: clinical trials
